Science Group director buys shares worth £28,334

Published 25/03/2025, 16:30
Science Group director buys shares worth £28,334

LONDON - Science Group plc (AIM:SAG), a company listed on the Alternative Investment Market (AIM), has reported that Daniel Edwards, the Group Managing Director, has purchased 6,667 ordinary shares at a price of 425 pence per share. The transaction took place on Monday and the shares acquired amount to an aggregate purchase price of £28,334.75.

Following this purchase, Edwards’s interest in the company has increased to approximately 0.22% of the issued share capital, excluding treasury shares, which equates to a total of 100,000 ordinary shares. This move by a key executive is often seen as a sign of confidence in the company’s future prospects.

The company has confirmed that the beneficial interests of all other directors in the share capital of Science Group remain unchanged from previous announcements. The notification of this dealing is in accordance with the requirements for the public disclosure of transactions by persons with managerial responsibilities.

The London Stock Exchange (LON:LSEG)’s AIMX was the platform where this transaction occurred. The company has not provided further details regarding the rationale behind Edwards’s purchase.

This latest development in the company’s share dealings has been announced in a press release statement, and it reflects a direct financial commitment by the Group Managing Director in the firm he manages.

Science Group is known for offering consultancy services in science and technology, and it operates under strict regulations that govern the conduct and reporting of transactions by its directors and other insiders.

Investors and market watchers often monitor director dealings as they may provide insights into the confidence levels of a company’s management in its own business operations and financial health. However, such transactions do not necessarily predict future performance and should be considered as part of a broader investment strategy.

The company has made no additional comments on the transaction at this time.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.